PyInvesting

Market research

ABVX.PA ABIVAX Société Anonyme

PA EUR Healthcare

Latest close

76.10 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
7B
P/E ratio
Not available
Analyst target
131.7201
Dividend yield
Not available
Beta
-0.33

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

ABIVAX Société Anonyme is currently in a long term uptrend where the price is trading 15.6% above its 200 day moving average.

From a valuation standpoint, the stock is 3733.7% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10480.4.

ABIVAX Société Anonyme's total revenue sank by 0.0% to $20K since the same quarter in the previous year.

Its net income has dropped by 0.0% to $-8M since the same quarter in the previous year.

Finally, its free cash flow grew by 47.7% to $-4M since the same quarter in the previous year.

Based on the above factors, ABIVAX Société Anonyme gets an overall score of 2/5.